Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for PROMACTA KIT
- Identification and Validation of Biomarkers for Breast Cancer Resistance Protein (BCRP)
- Pilot Trial of Eltrombopag in Patients Undergoing Chemotherapy for Malignant Solid Tumors
- Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease
- Eltrombopag vs. rhTPO to Increase Platelet Level After HSCT
- Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy
- Eltrombopag With Decitabine in Advanced Myelodysplastic Syndrome (MDS)
- Eltrombopag Olamine in Increasing Platelet Counts in Patients Undergoing Transplant
- Eltrombopag With or Without Hypomethylating Agent After Hypomethylating Agent Failure For Patients With Myelodysplastic Syndrome (MDS)
- Extended Dosing With Eltrombopag for Severe Aplastic Anemia
- Safety and Efficacy of Eltrombopag at Escalated Doses
- Study of Quadruple Therapy With Eltrombopag for Chronic Hepatitis C
- Lenalidomide and Eltrombopag Olamine in Treating Patients With Symptomatic Anemia in Low or Intermediate Myelodysplastic Syndrome
- Trial of Eltrombopag During Consolidation Therapy in Adults With AML in Complete Remission
- Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia
- Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia
- Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia
- WEUSKOP5410: Observational Study in ENABLE Clinical Trials
- A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia
- A Phase 3, Multicenter, Randomized, Double-blind,Active-controlled, Parallel-group Trial With an Open-labelExtension Phase to Evaluate the Efficacy and Safety of OralE5501 Versus Eltrombopag, in Adults With Chronic ImmuneThrombocytopenia (Idiopathic
- Eltrombopag Olamine in Treating Thrombocytopenia in Patients With Chronic Myeloid Leukemia or Myelofibrosis Receiving Tyrosine Kinase Therapy
- Eltrombopag in Thrombocytopenic Chronic Lymphocytic Leukemia (CLL) Patients (CLL2S Study of GCLLSG)
- Phase II Eltrombopag in Chronic Lymphocytic Leukemia (CLL)
- Efficacy of Eltrombopag to Improve Thrombocytopenia of MYH9-related Disease
- Promacta Pregnancy Registry
- Milk-only Lactation Study for Patients on Eltrombopag
- Eltrombopag for Post Transplant Thrombocytopenia
- Clinical Trial for Non-responders Who Previously Participated in Eltrombopag Studies TPL 103922 or TPL 108390
- A Pilot Study of a Thrombopoietin-Receptor Agonist, Eltrombopag, in Patients With Low to Int-2 Risk Myelodysplastic Syndrome (MDS)
- A Pilot Study of the Thrombopoietin-Receptor Agonist Eltrombopag in Refractory Aplastic Anemia Patients
- Thrombocytopenia and Bleeding in Wiskott-Aldrich Syndrome (WAS) Patients
- LENS - Long-term Eltrombopag Observational Study
Clinical trials list
click for details